|
|
Volumn 28, Issue 9, 2010, Pages 879-880
|
|
Avastin's commercial march suffers setback
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BEVACIZUMAB;
CARBOPLATIN;
FLUOROURACIL;
PACLITAXEL;
TRASTUZUMAB;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
COLORECTAL CANCER;
DRUG APPROVAL;
DRUG MECHANISM;
FOOD AND DRUG ADMINISTRATION;
GLIOBLASTOMA;
HUMAN;
KIDNEY CARCINOMA;
LUNG NON SMALL CELL CANCER;
NOTE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
TREATMENT RESPONSE;
ANTIBODIES, MONOCLONAL;
BREAST NEOPLASMS;
DRUG APPROVAL;
FEMALE;
HUMANS;
RECEPTOR, ERBB-2;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 77956666250
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0910-879 Document Type: Note |
|
Times cited : (10)
|
|
References (0)
|
